<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Compound Screening</title>
	<atom:link href="http://www.bioscreening.net/category/news/compound-screening/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Nigeria: FG and Cost of Cancer Screening</title>
		<link>http://www.bioscreening.net/2011/11/28/nigeria-fg-and-cost-of-cancer-screening/</link>
		<comments>http://www.bioscreening.net/2011/11/28/nigeria-fg-and-cost-of-cancer-screening/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 18:03:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1352</guid>
		<description><![CDATA[THE Federal Government&#8217;s recent directive to its hospitals to reduce the cost of cancer screening, though very commendable, is long overdue, considering that late diagnosis of the disease has resulted in the high rate of cancer related deaths in the country. Cancer is one of the leading causes of deaths in the world, especially in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/nigeria-fg-and-cost-of-cancer-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NMR Fine-Tuned for High-Content Metabolomics Screening</title>
		<link>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/</link>
		<comments>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:48:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1350</guid>
		<description><![CDATA[Scientists report on the development of a nuclear magnetic resonance (NMR)-based method forscreening the metabolomic response of drug-treated mammalian cells to drug therapy. TheSanford-Burnham Medical Research Institute, and Rady Children’s Hospital investigators, say the highly sensitive, fast, and simple method is carried out in 96-well format, and could have particular utility as a method for high-throughput [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fragment Library</title>
		<link>http://www.bioscreening.net/2010/12/20/fragment-library/</link>
		<comments>http://www.bioscreening.net/2010/12/20/fragment-library/#comments</comments>
		<pubDate>Mon, 20 Dec 2010 18:59:24 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1069</guid>
		<description><![CDATA[Thermo Fisher Scientific Inc. announced that its Maybridge Ro3 Diversity Fragment Library has helped researchers validate an emerging technique for drug discovery that targets key protein receptors involved in a wide range of biological functions. David Myszka, founder of Biosensor Tools LLC and director of the Center for Biomolecular Interaction Analysis at the University of [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/12/20/fragment-library/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jet Lag Pill to Slow Down Body Clock</title>
		<link>http://www.bioscreening.net/2010/12/16/jet-lag-pill-to-slow-down-body-clock/</link>
		<comments>http://www.bioscreening.net/2010/12/16/jet-lag-pill-to-slow-down-body-clock/#comments</comments>
		<pubDate>Thu, 16 Dec 2010 14:57:36 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1061</guid>
		<description><![CDATA[Scientists are one step closer to developing a jet lag pill that could relieve millions of long-haul passengers from sleepless nights and mid-afternoon drowsiness. Using automated screening techniques developed by pharmaceutical companies to find new drugs, researchers from UC San Diego and three other research institutions have discovered a molecule with the most potent effects [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/12/16/jet-lag-pill-to-slow-down-body-clock/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Virtual Screening</title>
		<link>http://www.bioscreening.net/2010/10/11/virtual-screening/</link>
		<comments>http://www.bioscreening.net/2010/10/11/virtual-screening/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 13:46:16 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[HT Screening]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1036</guid>
		<description><![CDATA[1. Description 1. Virtual screening (VS) can be a useful alternative to HTS, especially if the assay will only permit a relatively small number of compounds to be tested. Different methods can be used depending on the information available. For any virtual screening, the selection of the database is as important as the methods used. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/10/11/virtual-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography–tandem mass spectrometry</title>
		<link>http://www.bioscreening.net/2010/10/11/an-automated-screening-method-for-drugs-and-toxic-compounds-in-human-serum-and-urine-using-liquid-chromatography%e2%80%93tandem-mass-spectrometry/</link>
		<comments>http://www.bioscreening.net/2010/10/11/an-automated-screening-method-for-drugs-and-toxic-compounds-in-human-serum-and-urine-using-liquid-chromatography%e2%80%93tandem-mass-spectrometry/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 13:44:18 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1034</guid>
		<description><![CDATA[Stefan Sturma, Felix Hammannb, Juergen Dreweb, Hans H. Maurerc and André Scholera, Corresponding Author Contact Information, E-mail The Corresponding Author a University Hospital of Basel, Laboratory Medicine, Clinical Chemistry Laboratory, Petersgraben 4, CH-4031 Basel, Switzerland b University Hospital of Basel, Clinical Pharmacology and Toxicology, Basel, Switzerland c Saarland University, Department of Experimental and Clinical Toxicology, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/10/11/an-automated-screening-method-for-drugs-and-toxic-compounds-in-human-serum-and-urine-using-liquid-chromatography%e2%80%93tandem-mass-spectrometry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular Target for Screening:  G-Protein-Coupled Receptors</title>
		<link>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/</link>
		<comments>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 19:10:41 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1021</guid>
		<description><![CDATA[Newark, DE. August, 2010 – Press Release &#8211; TimTec, LLC. &#8211; Molecular Target for Screening:  G-Protein-Coupled Receptors, ActiTarg-G G-Protein-Coupled Receptors are the largest gene families in the human genome and, rightfully so, have become the leading molecular target in 2008. In 2009 SBS April meeting in Lille, France, followed-up with screening trends report stating that  [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screen for molecules that inhibit formation of A-beta oligomers</title>
		<link>http://www.bioscreening.net/2010/08/05/screen-for-molecules-that-inhibit-formation-of-a-beta-oligomers/</link>
		<comments>http://www.bioscreening.net/2010/08/05/screen-for-molecules-that-inhibit-formation-of-a-beta-oligomers/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 18:00:42 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Compound Screening]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1014</guid>
		<description><![CDATA[Alzheimer’s disease (AD) is a devastating neurological disorder characterized by the deposition of aggregated proteins in the brain in the form of extracellular beta-amyloid in senile plaques and intracellular tau in neurofibrillary tangles. A current approach towards treatment of Alzheimer’s disease is by using inhibitors of amyloid beta aggregation. Current screening protocols for inhibitors of [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/08/05/screen-for-molecules-that-inhibit-formation-of-a-beta-oligomers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The NIH Molecular Libraries Program: Identifying Chemical Probes for New Medicines</title>
		<link>http://www.bioscreening.net/2010/07/12/the-nih-molecular-libraries-program-identifying-chemical-probes-for-new-medicines/</link>
		<comments>http://www.bioscreening.net/2010/07/12/the-nih-molecular-libraries-program-identifying-chemical-probes-for-new-medicines/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 18:12:01 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/12/the-nih-molecular-libraries-program-identifying-chemical-probes-for-new-medicines/</guid>
		<description><![CDATA[Alice McCarthy In 2003, several program leaders within theÂ National Institutes of Health (NIH) recognized that the results from the recently completed Human Genome Project were a launching pad for further study. Now that scientists knew the genome, how could they determine gene function? In particular, how could scientists find specific biological pathways and targets that [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/12/the-nih-molecular-libraries-program-identifying-chemical-probes-for-new-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increasing The Odds Of Hit Iidentification By Screening Against Receptor Homologs</title>
		<link>http://www.bioscreening.net/2010/07/12/increasing-the-odds-of-hit-iidentification-by-screening-against-receptor-homologs/</link>
		<comments>http://www.bioscreening.net/2010/07/12/increasing-the-odds-of-hit-iidentification-by-screening-against-receptor-homologs/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 14:31:28 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/12/increasing-the-odds-of-hit-iidentification-by-screening-against-receptor-homologs/</guid>
		<description><![CDATA[Abstractâ€” Increasing the odds of hit identification in screening is of significance for drug discovery. The odds for finding a hit are closely related either to the diversity of libraries or to the availability of focused libraries. There are no truly diverse libraries and it is difficult to design focused libraries without sufficient information. Hence [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/12/increasing-the-odds-of-hit-iidentification-by-screening-against-receptor-homologs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Over 5 million compounds screened</title>
		<link>http://www.bioscreening.net/2010/07/12/over-5-million-compounds-screened/</link>
		<comments>http://www.bioscreening.net/2010/07/12/over-5-million-compounds-screened/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 13:57:11 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/12/over-5-million-compounds-screened/</guid>
		<description><![CDATA[Data from three projects released into the public domain In its search for new molecules against malaria, MMV has so far supported the screening of more than 5 million compounds for their potential activity against the malaria parasite. Three partners of the MMV-supported early discovery projects have gone a step further and released the data [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/12/over-5-million-compounds-screened/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increased R&amp;D Efforts Are Overcoming Obstacles and Showing Potential</title>
		<link>http://www.bioscreening.net/2010/07/12/911/</link>
		<comments>http://www.bioscreening.net/2010/07/12/911/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 13:46:17 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/12/911/</guid>
		<description><![CDATA[Ion channels make good drug targetsâ€”they reside on the cell surface and are fast switching mechanisms. They act like cell transistors, controlling many cell processes. There are close to 500 types of ion channels, yet many remain undiscovered. This was mainly attributed to technology restraints, however, with the recent introduction of HT patch clamping, as [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/12/911/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study Shows How Worms Can Help Screen For New Drugs</title>
		<link>http://www.bioscreening.net/2010/07/07/new-study-shows-how-worms-can-help-screen-for-new-drugs/</link>
		<comments>http://www.bioscreening.net/2010/07/07/new-study-shows-how-worms-can-help-screen-for-new-drugs/#comments</comments>
		<pubDate>Wed, 07 Jul 2010 20:22:32 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/07/new-study-shows-how-worms-can-help-screen-for-new-drugs/</guid>
		<description><![CDATA[The humble nematode worm could prove of inestimable in screening new compounds on account of active drugs, chic enquiry published today suggests. Soil-homestead nematodes have a programmed avoidance response to harmful chemicals, which they detect from one end to the other nerves exposed to their conditions. Scientists led by the Wellcome Sureness Sanger Start possess [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/07/new-study-shows-how-worms-can-help-screen-for-new-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Â« Community Group Loses City Funding More Restaurants on Noe Valleyâ€™s 24th Street? Â» UCSF Lab Uses Brains &amp; Street Smarts to Fight Deadly Parasite</title>
		<link>http://www.bioscreening.net/2010/05/12/%c2%ab-community-group-loses-city-funding-more-restaurants-on-noe-valley%e2%80%99s-24th-street-%c2%bb-ucsf-lab-uses-brains-street-smarts-to-fight-deadly-parasite/</link>
		<comments>http://www.bioscreening.net/2010/05/12/%c2%ab-community-group-loses-city-funding-more-restaurants-on-noe-valley%e2%80%99s-24th-street-%c2%bb-ucsf-lab-uses-brains-street-smarts-to-fight-deadly-parasite/#comments</comments>
		<pubDate>Wed, 12 May 2010 18:46:45 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/%c2%ab-community-group-loses-city-funding-more-restaurants-on-noe-valley%e2%80%99s-24th-street-%c2%bb-ucsf-lab-uses-brains-street-smarts-to-fight-deadly-parasite/</guid>
		<description><![CDATA[A few years ago a chemist made an offer under the table to Jim McKerrow, a professor at UC San Franciscoâ€™s Mission Bay campus. McKerrow accepted and drove down to South San Francisco, backed his car up to a loading dock, filled the trunk, and drove away. â€œSuddenly I think, oh wow. What if I [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/%c2%ab-community-group-loses-city-funding-more-restaurants-on-noe-valley%e2%80%99s-24th-street-%c2%bb-ucsf-lab-uses-brains-street-smarts-to-fight-deadly-parasite/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evotec Extends and Broadens Research Agreement with Cubist Pharmaceuticals</title>
		<link>http://www.bioscreening.net/2010/05/12/evotec-extends-and-broadens-research-agreement-with-cubist-pharmaceuticals/</link>
		<comments>http://www.bioscreening.net/2010/05/12/evotec-extends-and-broadens-research-agreement-with-cubist-pharmaceuticals/#comments</comments>
		<pubDate>Wed, 12 May 2010 18:37:26 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/evotec-extends-and-broadens-research-agreement-with-cubist-pharmaceuticals/</guid>
		<description><![CDATA[Evotec AG / Evotec Extends and Broadens Research Agreement with Cubist Pharmaceuticals processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. - Collaboration expanded to include integrated fragment-based drug discovery activities on additional antibacterial targets &#8211; Hamburg, Germany &#8211; 25 February 2010: Evotec AG (Frankfurt Stock Exchange: [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/evotec-extends-and-broadens-research-agreement-with-cubist-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genentech and UCSFâ€™s Small Molecule Discovery Center Ink Deal Targeting Neurodegenerative Diseases</title>
		<link>http://www.bioscreening.net/2010/05/12/genentech-and-ucsf%e2%80%99s-small-molecule-discovery-center-ink-deal-targeting-neurodegenerative-diseases/</link>
		<comments>http://www.bioscreening.net/2010/05/12/genentech-and-ucsf%e2%80%99s-small-molecule-discovery-center-ink-deal-targeting-neurodegenerative-diseases/#comments</comments>
		<pubDate>Wed, 12 May 2010 18:26:30 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/genentech-and-ucsf%e2%80%99s-small-molecule-discovery-center-ink-deal-targeting-neurodegenerative-diseases/</guid>
		<description><![CDATA[The University of California, San Francisco and Genentech are partnering to discover and develop drug candidates for neurodegenerative diseases. The company will support the work of several researchers at the UCSF Small Molecule Discovery Center (SMDC) to progress prior SMDC research and Genentech discoveries. In addition to receiving financial support for its research function, UCSF [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/genentech-and-ucsf%e2%80%99s-small-molecule-discovery-center-ink-deal-targeting-neurodegenerative-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study looks at shifting energy metabolism</title>
		<link>http://www.bioscreening.net/2010/05/12/study-looks-at-shifting-energy-metabolism/</link>
		<comments>http://www.bioscreening.net/2010/05/12/study-looks-at-shifting-energy-metabolism/#comments</comments>
		<pubDate>Wed, 12 May 2010 18:25:00 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/study-looks-at-shifting-energy-metabolism/</guid>
		<description><![CDATA[U.S. scientists say they are using a novel screening technique to identify new effects of drugs in shifting cellular energy metabolism.Researchers at Massachusetts General Hospital, which led the study, said drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions, including heart attack and stroke. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/study-looks-at-shifting-energy-metabolism/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Home Â» content Shifting cellular energy metabolism may help treat cardiovascular disease</title>
		<link>http://www.bioscreening.net/2010/05/12/home-%c2%bb-content-shifting-cellular-energy-metabolism-may-help-treat-cardiovascular-disease/</link>
		<comments>http://www.bioscreening.net/2010/05/12/home-%c2%bb-content-shifting-cellular-energy-metabolism-may-help-treat-cardiovascular-disease/#comments</comments>
		<pubDate>Wed, 12 May 2010 17:49:51 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/home-%c2%bb-content-shifting-cellular-energy-metabolism-may-help-treat-cardiovascular-disease/</guid>
		<description><![CDATA[Drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions including heart attack and stroke. Using a new way to screen for potential drugs, a team led by Massachusetts General Hospital (MGH) researchers has identified several FDA-approved agents, including an over-the-counter anti-nausea drug, that can [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/home-%c2%bb-content-shifting-cellular-energy-metabolism-may-help-treat-cardiovascular-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Eli Lilly and GlaxoSmithKline: A Tale of Two Different Pharmas</title>
		<link>http://www.bioscreening.net/2010/05/12/eli-lilly-and-glaxosmithkline-a-tale-of-two-different-pharmas/</link>
		<comments>http://www.bioscreening.net/2010/05/12/eli-lilly-and-glaxosmithkline-a-tale-of-two-different-pharmas/#comments</comments>
		<pubDate>Wed, 12 May 2010 17:10:13 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/eli-lilly-and-glaxosmithkline-a-tale-of-two-different-pharmas/</guid>
		<description><![CDATA[New models for drug development, especially in big pharma, are being experimented by different companies. Eli Lilly (LLY) and GlaxoSmithKline (GSK) have two different models. These models do not throw out the old ones &#8211; but do offer additional routes going forward. Lilly has a Phenotypic Drug Discover Initiative, (or PD2), launched in 2009. Lilly [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/eli-lilly-and-glaxosmithkline-a-tale-of-two-different-pharmas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Create New Way to Screen Libraries of 10 Million or More Compounds</title>
		<link>http://www.bioscreening.net/2010/05/12/scientists-create-new-way-to-screen-libraries-of-10-million-or-more-compounds/</link>
		<comments>http://www.bioscreening.net/2010/05/12/scientists-create-new-way-to-screen-libraries-of-10-million-or-more-compounds/#comments</comments>
		<pubDate>Wed, 12 May 2010 16:53:40 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/05/12/scientists-create-new-way-to-screen-libraries-of-10-million-or-more-compounds/</guid>
		<description><![CDATA[The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through &#8212; time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/05/12/scientists-create-new-way-to-screen-libraries-of-10-million-or-more-compounds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

